315 related articles for article (PubMed ID: 27363029)
41. Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas.
Meltzer SJ; Yin J; Manin B; Rhyu MG; Cottrell J; Hudson E; Redd JL; Krasna MJ; Abraham JM; Reid BJ
Cancer Res; 1994 Jul; 54(13):3379-82. PubMed ID: 8012954
[TBL] [Abstract][Full Text] [Related]
42. Gene expression profiling reveals stromal genes expressed in common between Barrett's esophagus and adenocarcinoma.
Hao Y; Triadafilopoulos G; Sahbaie P; Young HS; Omary MB; Lowe AW
Gastroenterology; 2006 Sep; 131(3):925-33. PubMed ID: 16952561
[TBL] [Abstract][Full Text] [Related]
43. Neuroendocrine in Barrett's mucosa and adenocarcinomas of the gastroesophageal junction.
Koppert LB; Wijnhoven BP; Tilanus HW; Stijnen T; Van Dekken H; Dinjens WN
Int J Surg Pathol; 2004 Apr; 12(2):117-25. PubMed ID: 15173916
[TBL] [Abstract][Full Text] [Related]
44. TGM2: a cell surface marker in esophageal adenocarcinomas.
Leicht DT; Kausar T; Wang Z; Ferrer-Torres D; Wang TD; Thomas DG; Lin J; Chang AC; Lin L; Beer DG
J Thorac Oncol; 2014 Jun; 9(6):872-81. PubMed ID: 24828664
[TBL] [Abstract][Full Text] [Related]
45. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia.
Cameron AJ; Souto EO; Smyrk TC
Am J Gastroenterol; 2002 Jun; 97(6):1375-80. PubMed ID: 12094853
[TBL] [Abstract][Full Text] [Related]
46. Complex structural rearrangements are present in high-grade dysplastic Barrett's oesophagus samples.
Newell F; Patel K; Gartside M; Krause L; Brosda S; Aoude LG; Loffler KA; Bonazzi VF; Patch AM; Kazakoff SH; Holmes O; Xu Q; Wood S; Leonard C; Lampe G; Lord RV; Whiteman DC; Pearson JV; Nones K; Waddell N; Barbour AP
BMC Med Genomics; 2019 Feb; 12(1):31. PubMed ID: 30717762
[TBL] [Abstract][Full Text] [Related]
47. P53 mutational status improves estimation of prognosis in patients with curatively resected adenocarcinoma in Barrett's esophagus.
Schneider PM; Stoeltzing O; Roth JA; Hoelscher AH; Wegerer S; Mizumoto S; Becker K; Dittler HJ; Fink U; Siewert JR
Clin Cancer Res; 2000 Aug; 6(8):3153-8. PubMed ID: 10955797
[TBL] [Abstract][Full Text] [Related]
48. Molecular targets for treatment of Barrett's esophagus.
Feagins LA; Souza RF
Dis Esophagus; 2005; 18(2):75-86. PubMed ID: 16053481
[TBL] [Abstract][Full Text] [Related]
49. [Polymorphism/loss of heterozygosity of APC gene in GERD-Barrett's metaplasia-dysplasia-adenocarcinoma sequence].
Mokrowiecka A; Wierzchniewska-Ławska A; Smolarz B; Romanowicz-Makowska H; Malecka-Panas E
Pol Merkur Lekarski; 2009 May; 26(155):385-9. PubMed ID: 19606680
[TBL] [Abstract][Full Text] [Related]
50. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
[TBL] [Abstract][Full Text] [Related]
51. Esophageal adenocarcinoma arising in cervical inlet patch with synchronous Barrett's esophagus-related dysplasia.
Tanaka M; Ushiku T; Ikemura M; Shibahara J; Seto Y; Fukayama M
Pathol Int; 2014 Aug; 64(8):397-401. PubMed ID: 25143128
[TBL] [Abstract][Full Text] [Related]
52. Similarity of aberrant DNA methylation in Barrett's esophagus and esophageal adenocarcinoma.
Smith E; De Young NJ; Pavey SJ; Hayward NK; Nancarrow DJ; Whiteman DC; Smithers BM; Ruszkiewicz AR; Clouston AD; Gotley DC; Devitt PG; Jamieson GG; Drew PA
Mol Cancer; 2008 Oct; 7():75. PubMed ID: 18831746
[TBL] [Abstract][Full Text] [Related]
53. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
54. Identification of Barrett's esophagus in relatives by endoscopic screening.
Chak A; Faulx A; Kinnard M; Brock W; Willis J; Wiesner GL; Parrado AR; Goddard KA
Am J Gastroenterol; 2004 Nov; 99(11):2107-14. PubMed ID: 15554988
[TBL] [Abstract][Full Text] [Related]
55. Epithelial PD-L2 Expression Marks Barrett's Esophagus and Esophageal Adenocarcinoma.
Derks S; Nason KS; Liao X; Stachler MD; Liu KX; Liu JB; Sicinska E; Goldberg MS; Freeman GJ; Rodig SJ; Davison JM; Bass AJ
Cancer Immunol Res; 2015 Oct; 3(10):1123-1129. PubMed ID: 26081225
[TBL] [Abstract][Full Text] [Related]
56. Expression of calcium-binding proteins S100A2 and S100A4 in Barrett's adenocarcinomas.
Lee OJ; Hong SM; Razvi MH; Peng D; Powell SM; Smoklin M; Moskaluk CA; El-Rifai W
Neoplasia; 2006 Oct; 8(10):843-50. PubMed ID: 17032501
[TBL] [Abstract][Full Text] [Related]
57. Barrett's esophagus: the long and the short of it.
Nandurkar S; Talley NJ
Am J Gastroenterol; 1999 Jan; 94(1):30-40. PubMed ID: 9934728
[TBL] [Abstract][Full Text] [Related]
58. Barrett's esophagus and risk of esophageal adenocarcinoma.
Cossentino MJ; Wong RK
Semin Gastrointest Dis; 2003 Jul; 14(3):128-35. PubMed ID: 14653412
[TBL] [Abstract][Full Text] [Related]
59. Overexpression of claudin proteins in esophageal adenocarcinoma and its precursor lesions.
Montgomery E; Mamelak AJ; Gibson M; Maitra A; Sheikh S; Amr SS; Yang S; Brock M; Forastiere A; Zhang S; Murphy KM; Berg KD
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):24-30. PubMed ID: 16540726
[TBL] [Abstract][Full Text] [Related]
60. Role of retinoid X receptor mRNA expression in Barrett's esophagus.
Brabender J; Lord RV; Metzger R; Park J; Salonga D; Danenberg KD; Hölscher AH; Danenberg PV; Schneider PM
J Gastrointest Surg; 2004; 8(4):413-22. PubMed ID: 15120365
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]